• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Humana's 2026 Medicare Advantage Plans Prioritize Simplicity, Stability and Quality Care for Beneficiaries

    10/1/25 7:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care
    Get the next $HUM alert in real time by email
    • More than 80% of Humana Medicare Advantage members will be in plans with stable benefits.
    • Humana Medicare Advantage plans include preventive and diagnostic screenings for breast cancer, colon cancer and bone density at no additional cost to members.
    • 100% of Humana Medicare Advantage plans include dental, vision and hearing coverage.

    Humana Inc. (NYSE:HUM), a leading health and well-being company, today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2026. During the Medicare Annual Election Period (AEP) Oct. 15-Dec. 7, Medicare beneficiaries may review plan changes for the coming year and select a plan to meet their evolving healthcare needs.

    "For decades, Humana has been dedicated to making healthcare easy to navigate for Medicare beneficiaries, offering clear and consistent options that prioritize stability, quality and affordability," said George Renaudin, President of Insurance at Humana. "Our 2026 plans reflect valuable feedback from Humana members and a sustained commitment to supporting the health and independence of our members."

    Thoughtful plan design offers cost predictability and benefit consistency, helping members plan for their healthcare needs with confidence. Humana's Medicare Advantage plans include medical, dental, vision, hearing and—in many cases—prescription drug coverage.

    Commitment to Simplicity and Clarity. Humana's 2026 Medicare Advantage plans are designed to be straightforward and stress-free, making it easier for members to understand and use their benefits. Standardized plan offerings and easy-to-understand plan materials are designed to support confident decision-making.

    Focusing on Member Priorities. Benefits for 2026 reflect input from thousands of Medicare members, helping ensure the features they value most remain in place.

    • All Humana non-special needs Medicare Advantage plans include dental, vision and hearing coverage; $0 copays for covered preventive dental services; and $0 copays for in-network preventive services. Nearly all of these plans also include $0 in-network copays for primary care provider (PCP) visits and $0 copays on Tier 1 prescriptions.
    • All Humana's Dual-eligible Special Needs Plans (DSNP) include $0 copays for preventive services; $0 copays for covered vaccinations; care management support to manage complex chronic conditions; and dental, vision and hearing coverage. Most DSNPs also include a Healthy Options Allowance to help pay for covered over-the-counter items as well as $0 copays on hundreds of prescriptions.

    Primary Care and Prevention. Humana's focus on primary and preventive care supports our members, especially older adults, in maintaining independence. Primary care visits provide opportunities for early detection and chronic condition management, supporting improved clinical outcomes and helping reduce unnecessary emergency room visits.

    Expanded Screenings and Wellness Support. Preventive and diagnostic screenings for breast cancer, colon cancer and bone density are now included in Humana's Medicare Advantage plans at no additional cost to members. Humana continues to invest in innovative wellness programs, such as Go365, to empower members to stay proactive about their health while being rewarded for taking certain healthy actions.

    Prescription Drug Plans: Lower Premiums, Stronger Value. Humana's stand-alone Prescription Drug Plans (PDP) for 2026 are designed to make prescription coverage more affordable and easier to access for Medicare beneficiaries nationwide. Approximately 83% of Humana PDPs will feature a premium decrease, and the maximum out-of-pocket for covered prescriptions, set by the Centers for Medicare & Medicaid (CMS), will be $2,100 for the year.

    Humana continues to offer three distinct PDPs to meet a variety of needs: options focused on budget-conscious coverage, plans with robust generic drug value, and coverage for those seeking a broad formulary. These plans offer $0 copays for many common generic medications, no deductibles on select tiers, and access to an extensive national network of pharmacies. Medicare beneficiaries can select the plan in their area that best fits their priorities for cost savings, medication access, and coverage flexibility.

    Market Expansion and Increased Access. In 2026, Humana will have Medicare Advantage plan offerings in 46 states and Washington, D.C., covering 85% of U.S. counties. New plan types will be available in four states and 177 counties, broadening geographical access to coverage.

    Humana is expanding its Special Needs Plans (SNP) to new states to help more beneficiaries with special circumstances get the coverage and support they need.

    • D-SNPs (Dual Eligible) – Illinois
    • C-SNPs (Chronic Condition) – Idaho, Maine and New Jersey

    In 2026, Humana will introduce benefits to support members with End-Stage Renal Disease or Chronic Kidney Condition on certain non-special needs Medicare Advantage plans in Oklahoma, Texas, North Carolina and Virginia. While these plans are available to anyone with Medicare, Medicare Advantage members with eligible chronic conditions will receive additional benefits to support kidney health, such as $0 or low copays for visits at in-network dialysis centers coordinate care and transportation to and from eligible medical visits, including dialysis centers.

    All Humana Medicare Advantage and Prescription Drug Plan members have the option to use CenterWell Pharmacy, a home delivery pharmacy that helps customers manage their prescription and over-the-counter medications with convenient, safe and on-time deliveries by mail to their front doorsteps or locations of their choice.

    Humana has served Medicare beneficiaries for decades, with more than 8.2 million Medicare members as of June 30, 2025. About 5.8 million of those members are enrolled in a Medicare Advantage plan.

    For More Information. Humana offers in-person, online and telephone enrollment options. All enrollment options will connect Medicare beneficiaries with a licensed sales agent. For information about Humana's Medicare plan options available in your area, visit Humana.com/Medicare or call toll-free 1-800-706-1368 (TTY: 711). Licensed sales agents are available 8 a.m. to 8 p.m. local time, seven days a week. Spanish language resources are available here.

    About Humana

    Humana Inc. (NYSE:HUM) is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we strive to make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

    Additional Information

    Humana is a Medicare Advantage HMO, PPO, and PFFS organization and a stand-alone PDP prescription drug plan with a Medicare contract. $0 in-network PCP visit copays not included on Humana Value Plus H5216-382 (PPO) & Humana Value Plus H5525-041. Prescription drug coverage can vary across plans. $0 prescription drug copay may be limited to specific tiers, coverage stages, 3-month supply and certain mail-order pharmacies. Enrollment in any Humana plan depends on contract renewal. Other providers are available in the Humana network.

    Humana is also a Dual Eligible Special Needs [HMO PPO, PPO SNP] plan with a Medicare contract and a contract with the state Medicaid program. Florida: Humana is a DSNP with a Florida Medicaid Contract. The benefit information provided is a brief summary, not a complete description of benefits. For more information, contact the DSNP. Limitations, copayments and/or restrictions may apply. Benefits, formulary, pharmacy network, premium and/or copayments/co-insurance may change. Tennessee: TennCare is not responsible for payment for these benefits, except for appropriate cost sharing amounts. TennCare is not responsible for guaranteeing the availability or quality of these benefits. Any reference to more, extra, or additional Medicare benefits, is applicable to Medicare only and does not indicate increased Medicaid benefits. Humana Gold Plus SNP-DE H4461-038 (HMO D-SNP) is only available for residents in the Qualified Medicare Beneficiary (QMB) Only Program without other Medicaid. Dual Special Needs Plans have a $0 premium for members with Extra Help from Medicare (Low Income Subsidy). Members who don't qualify for Extra Help may have a premium of up to $41.50 a month in select markets. Dialysis visits may have a $30 copay in select markets.

    The Humana Premier RX Plan (PDP) and the Humana Value RX Plan (PDP) Prescription Drug Plan pharmacy networks include limited lower-cost, preferred pharmacies in urban areas of AR, CT, DE, IA, IN, KY, MA, MI, MN, MO, ND, NJ, NY, OH, RI, SD, TN, WI, WV; suburban areas of AZ, CT, DE, HI, IN, MA, MI, MN, MT, ND, NJ, NY, OH, PA, RI, WI, WV; and rural areas of AK, IA, MN, MT, ND, NE, SD, VT, WY. There are an extremely limited number of preferred cost share pharmacies in urban areas in the following states: DE, MI, MN, ND; suburban areas of MT and ND; and rural areas of ND. The lower costs advertised in our plan materials for these pharmacies may not be available at the pharmacy you use. For up-to-date information about our network pharmacies, including whether there are any lower-cost preferred pharmacies in your area, please call Customer Care at 1-800-281-6918 (TTY: 711) or consult the online pharmacy directory at Humana.com.

    Y0040_GHHMTKSEN_M

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251001265799/en/

    Kelli LeGaspi

    Humana Corporate Communications

    [email protected]

    Get the next $HUM alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HUM

    DatePrice TargetRatingAnalyst
    9/22/2025$295.00In-line
    Evercore ISI
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    11/6/2024$247.00 → $308.00Underperform → Neutral
    BofA Securities
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    10/8/2024$308.00Mkt Perform → Outperform
    Bernstein
    10/7/2024$402.00 → $261.00Buy → Hold
    TD Cowen
    10/7/2024$519.00 → $253.00Buy → Hold
    Jefferies
    10/3/2024$392.00 → $274.00Overweight → Neutral
    Piper Sandler
    More analyst ratings

    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI initiated coverage on Humana with a new price target

    Evercore ISI initiated coverage of Humana with a rating of In-line and set a new price target of $295.00

    9/22/25 8:31:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana upgraded by Raymond James with a new price target

    Raymond James upgraded Humana from Mkt Perform to Outperform and set a new price target of $315.00

    5/1/25 7:42:13 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana upgraded by BofA Securities with a new price target

    BofA Securities upgraded Humana from Underperform to Neutral and set a new price target of $308.00 from $247.00 previously

    11/6/24 8:21:46 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, Insurance Renaudin George Ii converted options into 609 units of Humana Common and covered exercise/tax liability with 240 units of Humana Common, increasing direct ownership by 2% to 16,071 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    10/3/25 9:13:54 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Feinberg David T

    4 - HUMANA INC (0000049071) (Issuer)

    10/2/25 1:07:38 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Hilzinger Kurt J

    4 - HUMANA INC (0000049071) (Issuer)

    10/2/25 11:50:49 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Humana's 2026 Medicare Advantage Plans Prioritize Simplicity, Stability and Quality Care for Beneficiaries

    More than 80% of Humana Medicare Advantage members will be in plans with stable benefits. Humana Medicare Advantage plans include preventive and diagnostic screenings for breast cancer, colon cancer and bone density at no additional cost to members. 100% of Humana Medicare Advantage plans include dental, vision and hearing coverage. Humana Inc. (NYSE:HUM), a leading health and well-being company, today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2026. During the Medicare Annual Election Period (AEP) Oct. 15-Dec. 7, Medicare beneficiaries may review plan changes for the coming year and select a plan to meet their evolving healthcare needs. "

    10/1/25 7:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Invites Everyone to Get in the Game With Pickleball Pop-Up Events

    Humana to offer court play, lessons, games, and healthy aging resources geared toward older adults of all experience levels at Simon® centers in Illinois, Indiana and Florida Humana Inc. (NYSE: HUM), a leading health and well-being company, is taking pickleball on the road to celebrate their ongoing commitment to creating experiences that enable health, enhance activity, and foster connectivity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250929806152/en/Humana is inviting older adults to 'get in the game' with pickleball pop-up events at malls in Illinois, Indiana and Florida in October. These events are designed to offer

    9/29/25 6:10:00 AM ET
    $HUM
    $SPG
    Medical Specialities
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus

    USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Sept. 25, 2025 /PRNewswire/ -- America's aging demographics are creating unprecedented demand for precision healthcare solutions, with population projections showing nearly one in four Americans will be over 65 by 2060[1]. Gene therapy approvals continue accelerating as the FDA recently approved breakthrough treatments targeting rare diseases[2], while AI-powered diagnostic platforms are transforming how clinicians detect conditions before symptoms appear[3]. These market-wide trends are positioning early-stage companies across diagnostics, gene therapy, and personalized medicine for significant growth

    9/25/25 9:15:00 AM ET
    $EDIT
    $HUM
    $QURE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Medical Specialities
    Biotechnology: Pharmaceutical Preparations

    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    5/16/25 4:48:13 PM ET
    $HUM
    Medical Specialities
    Health Care

    Mesquita Jorge S. bought $200,066 worth of Humana Common (545 units at $367.09) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/21/24 10:37:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    SEC Filings

    View All

    Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - HUMANA INC (0000049071) (Filer)

    10/2/25 12:00:03 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - HUMANA INC (0000049071) (Filer)

    8/29/25 4:30:11 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 10-Q filed by Humana Inc.

    10-Q - HUMANA INC (0000049071) (Filer)

    7/30/25 3:37:58 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Financials

    Live finance-specific insights

    View All

    Humana Board Declares Payment of Quarterly Dividend to Stockholders

    Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on October 31, 2025 to stockholders of record as of the close of business on September 26, 2025. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, mil

    8/21/25 4:15:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Reports Second Quarter 2025 Financial Results; Raises Full Year 2025 Adjusted EPS and Revenue Guidance

    Reports 2Q25 earnings per share (EPS) of $4.51 on a GAAP basis, Adjusted EPS of $6.27; reports YTD EPS of $14.81 on a GAAP basis, $17.85 on an Adjusted basis 2Q25 Insurance segment benefit ratio of 89.9 percent, in line with the company's previously disclosed expectation of 'approximately 90 percent' Updates FY 2025 GAAP EPS guidance to 'approximately $13.77' from the previous estimate of 'approximately $14.68'; raises Adjusted FY 2025 EPS guidance to 'approximately $17.00', up from the previous 'approximately $16.25' guidance Raises FY 2025 consolidated revenues guidance to 'at least $128 billion' compared to the previous guidance range of $126 billion to $128 billion Affirms

    7/30/25 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. to Release Second Quarter 2025 Results on July 30, 2025

    Humana will release its 2Q25 financial results, as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 30, 2025. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2025. A webcast of the 2Q25 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BIb5c00e1d1dc14cd7ad2b375d4f1cde21. Upon registration, telephone participants w

    7/9/25 4:15:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Leadership Updates

    Live Leadership Updates

    View All

    National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

    The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

    6/25/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

    Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

    6/18/25 8:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Announces CFO Transition

    Leading health and well-being company Humana Inc. (NYSE:HUM) announced today that Celeste Mellet will be appointed to succeed Susan Diamond as Chief Financial Officer (CFO), effective January 11, 2025. Diamond is stepping down after a successful 18-year career at Humana, including over three years as CFO, and will serve in an advisory role through the end of 2025 to ensure a smooth transition. "On behalf of the entire Board and management team, I want to extend my thanks to Susan for her leadership as CFO and in prior roles during her nearly two decades at Humana," said Jim Rechtin, Humana's President and Chief Executive Officer. "Susan's contributions spanned across our Medicare, Home So

    12/3/24 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/16/24 4:29:43 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/14/24 10:02:59 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/13/24 5:06:27 PM ET
    $HUM
    Medical Specialities
    Health Care